MedTrace Logo

A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

NCT02718352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2018-06-27

No results posted yet for this study

Summary

Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program

Conditions

  • Opioid Dependence

Interventions

OTHER

Naturalistic Prospective Cohort

Follow subjects through 1 year of naturalistic buprenorphine treatment

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Deepa Camenga, MD · Yale University

Eligibility

Min Age
16 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718352 on ClinicalTrials.gov